Use of an in vitro human skin permeation assay to assess bioequivalence of two topical cream formulations containing butenafine hydrochloride (1%, w/w)
- 1 December 2016
- journal article
- research article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 82, 14-19
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Current Challenges in Bioequivalence, Quality, and Novel Assessment Technologies for Topical ProductsPharmaceutical Research, 2014
- Percutaneous Absorption in Man: In vitro-in vivo CorrelationSkin Pharmacology and Physiology, 2011
- Bioequivalence for Topical Products—An UpdatePharmaceutical Research, 2010
- Use of Excised Human Skin to Assess the Bioequivalence of Topical ProductsSkin Pharmacology and Physiology, 2009
- Inter- and intra-individual variability in human skin barrier function: A large scale retrospective studyToxicology in Vitro, 2008
- FDA Critical Path Initiatives: Opportunities for Generic Drug DevelopmentThe AAPS Journal, 2008
- Multi-species assessment of electrical resistance as a skin integrity marker for in vitro percutaneous absorption studiesToxicology in Vitro, 2004
- Butenafine hydrochloride: for the treatment of interdigital tinea pedisExpert Opinion on Pharmacotherapy, 2000
- ButenafineDrugs, 1998